A Small-Molecule Mask for Traceless Protein Delivery
A Small-Molecule Mask for Traceless Protein Delivery
批准号:
9792256
负责人:
Lucas William Erickson
金额:
$5.29万
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-09-15 至 2020-07-13
关键词:
AdoptionAnimalsBindingBiological AssayBreast cancer metastasisCRISPR/Cas technologyCell LineCellsChemicalsChemistryCleaved cellCollagenComplexCytosolDNADNA deliveryDevelopmentEsterificationFluorescenceFutureGenesGenetic TranscriptionGlycocalyxGoalsGuide RNAHalf-LifeHumanIn VitroIsoelectric PointKnock-outLabelLengthMasksMass Spectrum AnalysisMethodsNeoplasm MetastasisPaperPeptidesPlasmidsProcessProcollagen-Proline DioxygenaseProdrugsProteinsRNARNA-Binding ProteinsReactionReagentResearch PersonnelSeriesSystemTechniquesTechnologyTherapeuticTransfectionViralWorkbasecarboxylatedesignesteraseexperimental groupexperimental studyfunctional groupgenome editingguanidiniumin vivolipid nanoparticlenanoGoldplasmid DNAprotein expressionside effectsmall moleculesuccesstooluptake
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY/ABSTRACT
The CRISPR/Cas9 system has quickly emerged as the most robust gene editing tool yet discovered. Many
early papers employing this system have utilized a plasmid that encodes the Cas9 protein and the guide RNA
(sgRNA). These plasmids are typically delivered in viral shells that can often be too small for the entire
plasmid, requiring multiple segments to be transported separately. Another drawback of plasmid incorporation
is the continual expression of the protein and RNA, which often leads to undesired off-target effects. A
promising alternative is the delivery of the Cas9·sgRNA complex directly. A variety of methods have been
developed for the delivery of this complex, including lipid nanoparticles and cell-penetrating peptides, but all
methods so far result in inefficient gene editing or are inapplicable in vivo (or both). Recent work in our lab has
demonstrated that the unique chemistry of the benzoxaborole functional group allows it to deliver proteins
efficiently and directly into the cytosol. Combining this unique chemistry with the reactivity of a diazo motif will
allow us to develop small molecules that can mask Cas9 carboxylates via an esterification reaction. A series of
these delivery vehicles will be synthesized and reacted with the Cas9·sgRNA complex to evaluate their effect
on complex stability and protein–RNA binding. Initial experiments will focus on knocking out the GFP gene in
GFP-producing HEK cells. Once the optimal delivery vehicle and conditions have been determined, that
vehicle will be employed as a tool in future studies of breast cancer metastasis. Collagen prolyl 4-hydroxylase
has been demonstrated to be significant in the metastasis process, and we anticipate that knock-out of this
gene via a CRISPR/Cas9 system would be an effective approach. Finally, our delivery strategy could provide a
straightforward method for delivering not only Cas9·sgRNA complexes, but also a wide variety of proteins.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金